A Phase I study of 'Tomudex' and gemcitabine in advanced cancer

被引：1
|
作者：
Cripps, C
Batist, G
Dahrouge, S
Fry, D
McQuillan, A
Kolendowicz, R
Abugaber, AA
机构：
[1] Ottawa Reg Canc Ctr, Ottawa, ON K1Y 4K7, Canada
[2] Jewish Gen Hosp, Clin Res Unit, Quebec City, PQ, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81582-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1162
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [41] A phase II study of gemcitabine and flutamide in advanced pancreatic cancer
    Mayer, A
    Shaw, J
    'Ath, SD
    Price, P
    Blesing, C
    Corrie, P
    BRITISH JOURNAL OF CANCER, 2000, 83 : 18 - 18
  • [42] Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study
    Kamath, Suneel D.
    Kalyan, Aparna
    Kircher, Sheetal
    Nimeiri, Halla
    Fought, Angela J.
    Benson, Al, III
    Mulcahy, Mary
    ONCOLOGIST, 2020, 25 (05): : E808 - E815
  • [43] 'Tomudex' (raltitrexed) and cisplatin in the treatment of patients with locally advanced or metastatic head and neck cancer (HNSCC): A Phase I/II study
    Huinink, DTB
    de Jong, RJB
    Verschuur, HP
    Keizer, HJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S175 - S175
  • [44] NCICCTG IND 98: A phase I dose escalation study of raltitrexed (Tomudex) Plus doxorubicin (DOX) in patients with advanced cancer
    Biarnason, G
    Charpentier, D
    Wong, R
    Goel, R
    Smith, M
    Abugaber, A
    Matthews, S
    Seymour, L
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [45] A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer
    Tomao, S
    Romiti, A
    Massidda, B
    Ionta, MI
    Farris, A
    Zullo, A
    Brescia, A
    Santuari, L
    Frati, L
    ANTICANCER RESEARCH, 2002, 22 (04) : 2361 - 2364
  • [46] A randomized phase II study of axitinib (AG-013736) and gemcitabine versus gemcitabine in advanced pancreatic cancer, preceded by a phase I component
    Spano, J.
    Chodkiewicz, C.
    Maurel, J.
    Wong, R. P.
    Wasan, H. S.
    Pithavala, Y. K.
    Bycott, P. W.
    Liau, K.
    Kim, S.
    Rixe, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Phase II study of raltitrexed (Tomudex®) in chemotherapy-pretreated patients with advanced colorectal cancer
    Sato, A
    Kurihara, M
    Horikoshi, N
    Aiba, K
    Kikkawa, N
    Shirouzu, K
    Mitachi, Y
    Sakata, Y
    Wakui, A
    ANTI-CANCER DRUGS, 1999, 10 (08) : 741 - 748
  • [48] Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors
    Chan, Emily
    Chiorean, E. Gabriela
    O'Dwyer, Peter J.
    Gabrail, Nashat Y.
    Alcindor, Thierry
    Potvin, Diane
    Chao, Richard
    Hurwitz, Herbert
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (02) : 355 - 364
  • [49] Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors
    Emily Chan
    E. Gabriela Chiorean
    Peter J. O’Dwyer
    Nashat Y. Gabrail
    Thierry Alcindor
    Diane Potvin
    Richard Chao
    Herbert Hurwitz
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 355 - 364
  • [50] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
12345